Glucose metabolism of TAMs in tumor chemoresistance and metastasis
- PMID: 37080816
- DOI: 10.1016/j.tcb.2023.03.008
Glucose metabolism of TAMs in tumor chemoresistance and metastasis
Abstract
Tumor-associated macrophages (TAMs) are critical in promoting tumor progression and therapeutic resistance. In adapting to metabolic changes in the tumor microenvironment (TME), TAMs reprogram their metabolisms and acquire immunosuppressive and pro-tumor properties. Increased glucose metabolism in TAMs leads to the accumulation of a variety of oncometabolites that exhibit potent tumor-promoting capacity via regulating gene expression and signaling transduction. Glucose uptake also fuels O-GlcNAcylation and other post-translational modifications to promote pro-tumor polarization and function of TAMs. Glucose metabolism coordinates interactions between TAMs and various types of cells in the TME, creating a complex network that facilitates tumor progression. Targeting glucose metabolism represents a promising strategy to switch TAMs from pro-tumor toward anti-tumor function for cancer therapy.
Keywords: O-GlcNAcylation; glucose metabolism; lactic acids; tumor metastasis; tumor-associated macrophages.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no conflicts of interest.
Similar articles
-
Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance.Cancer Cell. 2022 Oct 10;40(10):1207-1222.e10. doi: 10.1016/j.ccell.2022.08.012. Epub 2022 Sep 8. Cancer Cell. 2022. PMID: 36084651
-
Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors.Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188427. doi: 10.1016/j.bbcan.2020.188427. Epub 2020 Sep 20. Biochim Biophys Acta Rev Cancer. 2020. PMID: 32961257 Review.
-
Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.Chin Med J (Engl). 2022 Oct 20;135(20):2405-2416. doi: 10.1097/CM9.0000000000002426. Chin Med J (Engl). 2022. PMID: 36385099 Free PMC article. Review.
-
The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status.Curr Med Chem. 2021;28(39):8203-8236. doi: 10.2174/0929867328666210720143721. Curr Med Chem. 2021. PMID: 34303328 Review.
-
Immunometabolic attributes and mitochondria-associated signaling of Tumor-Associated Macrophages in tumor microenvironment modulate cancer progression.Biochem Pharmacol. 2023 Feb;208:115369. doi: 10.1016/j.bcp.2022.115369. Epub 2022 Dec 5. Biochem Pharmacol. 2023. PMID: 36481347 Review.
Cited by
-
A phosphoglycerate mutase 1 allosteric inhibitor restrains TAM-mediated colon cancer progression.Acta Pharm Sin B. 2024 Nov;14(11):4819-4831. doi: 10.1016/j.apsb.2024.09.007. Epub 2024 Sep 14. Acta Pharm Sin B. 2024. PMID: 39664444 Free PMC article.
-
Inhibition of glycolysis-driven immunosuppression with a nano-assembly enhances response to immune checkpoint blockade therapy in triple negative breast cancer.Nat Commun. 2023 Nov 2;14(1):7021. doi: 10.1038/s41467-023-42883-2. Nat Commun. 2023. PMID: 37919262 Free PMC article.
-
Knowledge structure analysis and network visualization of tumor-associated macrophages in hepatocellular carcinoma research: A bibliometric mapping.World J Clin Oncol. 2025 May 24;16(5):102747. doi: 10.5306/wjco.v16.i5.102747. World J Clin Oncol. 2025. PMID: 40503413 Free PMC article.
-
A Bibliometric Analysis of Metabolic Reprogramming in the Tumor Microenvironment From 2003 to 2022.Cancer Rep (Hoboken). 2024 Aug;7(8):e2146. doi: 10.1002/cnr2.2146. Cancer Rep (Hoboken). 2024. PMID: 39158178 Free PMC article. Review.
-
CpG-Based Nanovaccines Enhance Ovarian Cancer Immune Response by Gbp2-Mediated Remodeling of Tumor-Associated Macrophages.Adv Sci (Weinh). 2025 Apr;12(15):e2412881. doi: 10.1002/advs.202412881. Epub 2025 Feb 22. Adv Sci (Weinh). 2025. PMID: 39985265 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources